Physical symptoms like muscle weakness or tingling in extremities (if present) may start to improve
Nineteen percent of firms with 200 or more employees cover GLP-1s for weight loss in their largest health plan, according to KFFs most recent benefits survey, but coverage is more prevalent among firms with 5,000 or more workers (43%)
That pricing exposes two variables in the GLP-1 wars
When to seek medical attention If you experience chest pain or rash when taking metformin, seek emergency treatment
Review article: role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know
While GLP-1 receptor agonists have demonstrated significant potential as a powerful tool for weight loss and improved metabolic control, its essential to approach their use with a balanced perspective